While this science looks real, I’m curious about Sirtis.
“In 2008, GSK acquired David Sinclair’s biotech startup, Sirtris Pharmaceuticals, for $720 million. The goal was to develop resveratrol—a compound found in red wine—into drugs targeting the SIRT1 enzyme to treat age-related diseases. However, the endeavor eventually collapsed. Independent researchers and pharmaceutical teams (such as those at Pfizer and Amgen) published studies showing that neither resveratrol nor Sirtris's synthetic compounds directly hit the target SIRT1 enzyme.”
AI at UCL is taking over the world. I am pretty sure that no other university in the world - Stanford, MIT, Oxford, Cambridge, Tsinghua - are anywhere close to producing the number of AI unicorns. And, of course, UCL spin-off DeepMind, arguably, kick-started the entire 'recent' AI revolution. People think, wrongly, AI is a San Francisco (and US, China) - its a London thing.
https://t.co/0cdpxojKLo
£500m for UK AI startups is great. In the industrial revolution, UK pioneered electricity, sewage systems and trains. Now, the most expensive electricity, water has sewage and the slowest trains. Let’s learn from Germany, France, Japan with state-owned utilities – markets don’t always work.
@RishiSunak Says the guy who didn’t do anything of consequence for the UK. You started off well, then, decided to rule by focus group. You discarded your green and tech credentials and became over-the-top-anti-immigrant. You had so much potential.
20-something tech-bros out, 50/60-something PhDs in. This quarter SEED: Yann LeCun (65) $1B for AMI Labs, Fei-Fei Li (50) $1B for World Labs and David Silver (50) $1B for Ineffable Intelligence.